Patents Examined by Stephen Uyeno
-
Patent number: 9062325Abstract: The present invention provides an inbred corn line designated MFX7805, methods for producing a corn plant by crossing plants of the inbred line MFX7805 with plants of another corn plant. The invention further encompasses all parts of inbred corn line MFX7805, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line MFX7805, and plants produced according to these methods.Type: GrantFiled: February 27, 2013Date of Patent: June 23, 2015Assignee: Syngenta Participations AGInventor: David L. Beck
-
Patent number: 9055729Abstract: A soybean cultivar designated 36391644 is disclosed. The invention relates to the seeds of soybean cultivar 36391644, to the plants of soybean cultivar 36391644, to the plant parts of soybean cultivar 36391644, and to methods for producing progeny of soybean cultivar 36391644. The invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. The invention also relates to soybean cultivars or breeding cultivars, and plant parts derived from soybean cultivar 36391644. The invention also relates to methods for producing other soybean cultivars, lines, or plant parts derived from soybean cultivar 36391644, and to the soybean plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid soybean seeds, plants, and plant parts produced by crossing cultivar 36391644 with another soybean cultivar.Type: GrantFiled: May 8, 2014Date of Patent: June 16, 2015Assignees: Monsanto Technology LLC, Stine Seed Farm, Inc.Inventor: William H. Eby
-
Patent number: 9051569Abstract: The present invention is intended to provide means of pest control which achieve marked pest control effect. The pest control effect is achieved by the incorporation of an inhibitor (IAP inhibitor) against inhibitor of apoptosis (IAP) into the body of the target pest. The expression of the IAP is preferably inhibited by RNAi.Type: GrantFiled: June 4, 2010Date of Patent: June 9, 2015Assignee: National University Corporation Nagoya UniversityInventors: Teruyuki Niimi, Hirofumi Yoshioka, Yutaka Sato
-
Patent number: 9040774Abstract: This invention provides recombinant DNA constructs and methods for manipulating expression of a target gene that is regulated by a small RNA, by interfering with the binding of the small RNA to its target gene. More specifically, this invention discloses recombinant DNA constructs encoding cleavage blockers, 5-modified cleavage blockers, and translational inhibitors useful for modulating expression of a target gene and methods for their use. Further disclosed are miRNA targets useful for designing recombinant DNA constructs including miRNA-unresponsive transgenes, miRNA decoys, cleavage blockers, 5-modified cleavage blockers, and translational inhibitors, as well as methods for their use, and transgenic eukaryotic cells and organisms containing such constructs.Type: GrantFiled: July 1, 2009Date of Patent: May 26, 2015Assignee: Monsanto Technology LLCInventors: Sergey I. Ivashuta, Barbara E. Wiggins, Yuanji Zhang
-
Patent number: 9024110Abstract: This invention discloses the development of a novel platform for recombinant production of bioactive glycoproteins and cancer specific vaccines in plants. Plants and plant cell cultures have been humanized with respect to human mucin-type protein O-glycosylation. A panel of plant cell factories for production of recombinant glycoproteins with designed human O-glycosylation, including an improved cancer vaccine candidate, has been developed. The platform provides basis for i) production of an essentially unlimited array of O-glycosylated human glycoprotein therapeutics, such as human interferon ?2B and podoplanin, and ii) for further engineering of additional cancer specific O-glycans on glycoproteins of therapeutical value. Currently, mammalian cells are required for human O-glycosylation, but plants offer a unique cell platform for engineering O-glycosylation since they do not perform human type O-glycosylation.Type: GrantFiled: March 23, 2011Date of Patent: May 5, 2015Inventors: Zhang Yang, Damian Paul Drew, Emma Adhiambo Arigi, Peter Ulvskov, Steven B. Levery, Eric Bennett, Henrik Clausen, Brent Larsen Petersen
-
Patent number: 9018494Abstract: According to the invention, there is provided seed and plants of the hybrid corn variety designated CH819755. The invention thus relates to the plants, seeds and tissue cultures of the variety CH819755, and to methods for producing a corn plant produced by crossing a corn plant of variety CH819755 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH819755.Type: GrantFiled: May 28, 2013Date of Patent: April 28, 2015Assignee: Monsanto Technology LLCInventor: Marvin L. Boerboom
-
Patent number: 9018495Abstract: According to the invention, there is provided seed and plants of the hybrid corn variety designated CH028682. The invention thus relates to the plants, seeds and tissue cultures of the variety CH028682, and to methods for producing a corn plant produced by crossing a corn plant of variety CH028682 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH028682.Type: GrantFiled: May 28, 2013Date of Patent: April 28, 2015Assignee: Monsanto Technology LLCInventors: Scott A. Bergemann, Fufa H. Birru, Peter Guzman, Richard G. Stelpflug
-
Patent number: 9018496Abstract: According to the invention, there is provided seed and plants of the hybrid corn variety designated CH902675. The invention thus relates to the plants, seeds and tissue cultures of the variety CH902675, and to methods for producing a corn plant produced by crossing a corn plant of variety CH902675 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH902675.Type: GrantFiled: May 28, 2013Date of Patent: April 28, 2015Assignee: Monsanto Technology LLCInventors: Michael Dragonuk, Chris Eichhorn, Magen Starr Eller, Peter Guzman, Gregory J. Holland, Michael A. Josephs, Jeffrey L. McElroy, Laron L. Peters, Christopher L. Souder
-
Patent number: 9018448Abstract: The present invention pertains to a novel and extensive analytical platform for selecting genes with a possible commercial phenotype from a large group of candidate genes identified using tools in bioinformatics, data from EST sequencing and DNA array. An aspect of the invention provides a method of producing a transgenic plant having an increased growth compared to its wild type. The method comprises altering in the plant the level of a gene product of at least one gene specifically expressed during different phases of wood formation. Further aspects of the invention provide a plant cell or plant progeny of a transgenic plant comprising a recombinant polynucleotide according to the invention. Other aspects pertain a DNA construct comprising a nucleotide sequence of the invention and a plant cell or plant progeny comprising the DNA construct.Type: GrantFiled: December 4, 2007Date of Patent: April 28, 2015Assignee: SweTree Technologies ABInventors: Magnus Hertzberg, Göran Sandberg, Jarmo Schrader, Carl David Jonsén
-
Patent number: 9006410Abstract: Methods of increasing the yield in plant expression of recombinant proteins comprising engineering glycosylation sites into cloned genes or cDNAs for proteins using codons that drive post-translational modifications in plants and engineering the cloned genes or cDNAs to contain a plant secretory signal sequence that targets the gene products (protein) for secretion are present. The methods result in increased recombinant glycosylated protein yields. Proteins produced according to these methods are also present.Type: GrantFiled: February 2, 2011Date of Patent: April 14, 2015Assignee: Ohio UniversityInventors: Marcia J. Kieliszewski, Jianfeng Xu, Gary D. Meyer
-
Patent number: 8993844Abstract: Methods for the production of synthetic spider silk-like proteins in corn endosperm or plant shoot tissue are provided. The present invention provides further methods for the identification of synthetic spider silk-like proteins in corn endosperm or plant shoot tissue.Type: GrantFiled: May 27, 2011Date of Patent: March 31, 2015Assignee: University of WyomingInventors: Anne W. Sylvester, Randolph V. Lewis, David Jackson
-
Patent number: 8993839Abstract: Described herein are viral amplicon-based protein expression systems and methods useful for producing heterologous proteins, such as enzymes, by agroinfiltration. The methods involve producing an Agrobacterium with a Ti plasmid encoding a heterologous protein, infecting plant cells with the Agrobacterium, allowing expression of the heterologous protein, and recovering the heterologous protein from the plant cells. In one embodiment, the protein produced is an endoglucanase.Type: GrantFiled: July 19, 2011Date of Patent: March 31, 2015Assignee: The Regents of the University of CaliforniaInventors: Minsook Hwang, Benjamin E. Lindenmuth, Karen A. McDonald, Abhaya M. Dandekar, Bryce W. Falk, Sang-Kyu Jung, Nathaniel J. Kingsbury
-
Patent number: 8975471Abstract: The invention provides methods and compositions useful in target sequence suppression, target sequence validation and target sequence down regulation. The invention provides polynucleotide constructs useful for gene silencing or RNA down regulation, as well as cells, plants and seeds comprising the polynucleotides. The invention also provides a method for using microRNA to silence a target sequence or to down regulate RNA.Type: GrantFiled: October 12, 2005Date of Patent: March 10, 2015Assignee: The Rockefeller UniversityInventors: Jose L. Reyes Taboada, Xiuren Zhang, Takashi Soyano, Nam-Hai Chua, Qi-Wen Niu, Shih-Shun Lin
-
Patent number: 8969066Abstract: The present invention provides compositions and methods for producing flocculation moieties in photosynthetic organisms. The photosynthetic organisms are genetically modified to effect production, secretion, or both, of the flocculation moieties. Also provided are methods of flocculating organisms.Type: GrantFiled: June 26, 2009Date of Patent: March 3, 2015Assignee: Sapphire Energy, Inc.Inventors: Michael Mendez, Craig Behnke, Yan Poon, Philip Lee
-
Patent number: 8962918Abstract: The present invention provides isolated polynucleotide sequences encoding ?-mannosidase. The present invention further provides DNA constructs comprising the polynucleotide sequence coding for ?-mannosidase in sense or anti-sense orientation, RNAi constructs, recombinant vectors comprising the constructs, and host cells comprising the recombinant vector. The present invention further provides transgenic plants, plant cells, transgenic progeny and seeds expressing the polynucleotide with reduced ?-mannosidase protein accumulation, having enhanced fruit shelf life.Type: GrantFiled: July 9, 2009Date of Patent: February 24, 2015Assignee: National Institute of Plant Genome ResearchInventors: Asis Datta, Subhra Chakraborty, Niranjan Chakraborty, Sumit Ghosh, Vijaykumar Siddesh Meli
-
Patent number: 8940963Abstract: Process of producing in a plant, in plant tissue, or in plant cells a hetero-oligomeric protein comprising at least a first and a second protein subunit, said process comprising expressing in plant cells at least said first and said second protein subunit by (i) providing to said plant, said plant tissue or said plant cells a plus-sense single-stranded RNA viral vector encoding at least said first and said second protein subunit or (ii) providing to said plant, said plant tissue or said plant cells a first and a second plus-sense single-stranded RNA viral vector, said first viral vector encoding at least said first protein subunit, said second viral vector encoding at least said second protein subunit, whereby at least said first viral vector and said second viral vector are non-competing viral vectors.Type: GrantFiled: January 27, 2006Date of Patent: January 27, 2015Assignee: Icon Genetics GmbHInventors: Anatoly Giritch, Sylvestre Marillonnet, Victor Klimyuk, Yuri Gleba
-
Patent number: 8937233Abstract: According to the invention, there is provided seed and plants of the hybrid corn variety designated CH611134. The invention thus relates to the plants, seeds and tissue cultures of the variety CH611134, and to methods for producing a corn plant produced by crossing a corn plant of variety CH611134 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH611134.Type: GrantFiled: May 2, 2012Date of Patent: January 20, 2015Assignee: Monsanto Technology LLCInventors: Michael Dragonuk, Chris Eichhorn, Peter Guzman, Gregory J. Holland, Michael A. Josephs, Jeffrey L. McElroy, Laron L. Peters, Hector Ramirez de Leon, Christopher L. Souder
-
Patent number: 8937229Abstract: According to the invention, there is provided seed and plants of the corn variety designated CV025914. The invention thus relates to the plants, seeds and tissue cultures of the variety CV025914, and to methods for producing a corn plant produced by crossing a corn plant of variety CV025914 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety CV025914 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety CV025914.Type: GrantFiled: April 23, 2012Date of Patent: January 20, 2015Assignee: Monsanto Technology LLCInventor: Nathaniel J. Page
-
Patent number: 8937218Abstract: A transformed soybean plant having a gene encoding a modified seed storage protein introduced therein, obtained by inserting a gene encoding an Alzheimer's disease vaccine to a variable region(s) of a gene encoding a wild-type seed storage protein, is produced, and said vaccine is produced and accumulated in the seeds thereof.Type: GrantFiled: November 26, 2009Date of Patent: January 20, 2015Assignee: Hokko Chemical Industry Co., Ltd.Inventors: Teruhiko Terakawa, Hisakazu Hasegawa, Masao Ishimoto, Mikio Shoji, Takeshi Kawarabayashi, Yasuko Utsumi
-
Patent number: 8933297Abstract: The invention provides Nicotiana benthamiana mutant plants which are incapable of forming xylosyl-structures on glycoproteins. In addition, the invention provides methods for the production of heterologous glycoproteins in said mutant plants.Type: GrantFiled: June 10, 2010Date of Patent: January 13, 2015Assignee: Icon Genetics GmbHInventors: Koen Weterings, Gerben Van Eldik